BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Hoenle AG: Q2 FY25/26 Financial Outlook Revenue Growth EBITDA Forecast Q2 Results Sector Performance Hoenle AG
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Borussia Dortmund's Financial Update: Maintaining a BUY Recommendation Financial Results Buy Recommendation Borussia Dortmund EBITDA Decline UCL Exit
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Hoenle AG : Perspectives financières du deuxième trimestre de l'exercice 2025/26 Croissance Des Revenus Prévisions D'EBITDA Résultats Du Deuxième Trimestre Performance Sectorielle Hoenle AG
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Nabaltec AG Shows Resilience amid Economic Headwinds Revenue Growth Financial Performance BUY Rating Nabaltec AG Q1 2026
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Point sur la situation financière du Borussia Dortmund : maintien de la recommandation d'achat Résultats Financiers Recommandation D'achat Borussia Dortmund Baisse De L'EBITDA Sortie De L'UCL
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago Nabaltec AG fait preuve de résilience face aux difficultés économiques Performance Financière Croissance Des Revenus Nabaltec AG Évaluation D'achat 1er Trimestre 2026
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago FCA Admits Barclays Bank PLC Securities to Official List London Stock Exchange FCA Official List Securitised Derivatives Barclays Bank
BRIEF published on 05/05/2026 at 09:05, 4 months 6 days ago La FCA admet les titres de Barclays Bank PLC à la cote officielle FCA Bourse De Londres Liste Officielle Banque Barclays Produits Dérivés Titrisés
BRIEF published on 05/05/2026 at 08:57, 4 months 6 days ago Sartorius Stedim Biotech : Déclaration sur le Capital Social Nombre D'actions Droits De Vote Capital Social Transparence Financière Sartorius Stedim
BRIEF published on 05/05/2026 at 08:57, 4 months 6 days ago Sartorius Stedim Biotech Declares Share and Voting Rights Details French Regulations Sartorius Stedim Biotech Issued Capital Shares And Voting Rights April 2026 Data
Published on 09/11/2026 at 17:00, 2 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 30 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 5 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 30 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 1 hour 15 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour 30 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour 30 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
